Surgery and angiogenesis

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1654, Issue 1, 2004, Pages 95-104

  Van Der Bilt, Jarmila D W ^a   Borel Rinkes, Inne H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Angiogenesis; Anti angiogenic therapy; Hypoxia; Liver regeneration; Micrometastasis; Wound healing

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; CYTOTOXIC AGENT; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; PNU 145156; SEMAXANIB; THALIDOMIDE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VASOSTATIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BREAST CANCER; CANCER; CANCER PATIENT; CANCER SURGERY; CLINICAL TRIAL; COLON RESECTION; COLORECTAL CANCER; HUMAN; HYPOXIA; INJURY; KIDNEY CARCINOMA; LIVER CANCER; LIVER METASTASIS; LIVER REGENERATION; MELANOMA; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIDE EFFECT; SURGICAL TECHNIQUE; THROMBOEMBOLISM; WOUND; WOUND HEALING;

EID: 1242314762     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2004.01.003     Document Type: Review

References (128)

1. Drixler T.A., Voest E.E., van Vroonhoven T.J., Borel Rinkes I.M.H. Angiogenesis and surgery: from mice to man. Eur. J. Surg. 166:2000;435-446.
2. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9:2003;653-660.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31.
4. Dvorak H.F., Nagy J.A., Berse B., Brown L.F., Yeo K.T., Yeo T.K., Dvorak A.M., van de Water W.L., Sioussat T.M., Senger D.R. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann. N.Y. Acad. Sci. 667:1992;101-111.
5. Polverini P.J. The pathophysiology of angiogenesis. Crit. Rev. Oral Biol. Med. 6:1995;230-247.
6. Dvorak H.F. Tumors: wounds that do not heal, Similarity between tomor stroma generation and wound healing. N. Engl. J. Med. 315:1986;1650-1658.
7. Hofer S.O., Molema G., Hermens R.A., Wanebo H.J., Reichner J.S., Hoekstra H.J. The effect of surgical wounding on tumour development. Eur. J. Surg. Oncol. 25:1999;231-243.
8. McNamara D.A., Harmey J.H., Walsh T.N., Redmond H.P., Bouchier-Hayes D.J. Significance of angiogenesis in cancer therapy. Br. J. Surg. 85:1998;1044-1055.
9. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
10. Lorenz M., Muller H.H., Staib-Sebler E., Vetter G., Gog C., Petrowsky H., Kohne C.H. Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma. Langenbeck's Arch. Surg. 384:1999;328-338.
11. Gornet J.M., Azoulay D., Duclos-Vallee J.C., Goldwasser F. Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11. Anticancer Drugs. 11:2000;649-652.
12. Fong Y., Cohen A.M., Fortner J.G., Enker W.E., Turnbull A.D., Coit D.G., Marrero A.M., Prasad M., Blumgart L.H., Brennan M.F. Liver resection for colorectal metastases. J. Clin. Oncol. 15:1997;938-946.
13. Izzo F., Barnett C.C. Jr., Curley S.A. Radiofrequency ablation of primary and metastatic malignant liver tumors. Adv. Surg. 35:2001;225-250.
14. Bowles B.J., Machi J., Limm W.M., Severino R., Oishi A.J., Furumoto N.L., Wong L.L., Oishi R.H. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch. Surg. 136:2001;864-869.
15. Thomford N.R., Wooler L.B., Clagett O.T. The surgical treatment of metastatic tumors in the lungs. J. Thorac. Cardiovasc. Surg. 49:1965;357-363.
16. Mountain C.F., McMurtrey M.J., Hermes K.E. Surgery for pulmonary metastasis: a 20-year experience. Ann. Thorac. Surg. 38:1984;323-330.
17. Martini N., McCormack P.M. Evolution of the surgical management of pulmonary metastases. Chest Surg. Clin. North Am. 8:1998;13-27.
18. Hobson B., Denekamp J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br. J. Cancer. 49:1984;405-413.
19. Kerbel R.S. Tumor angiogenesis: past, present and the near future. Carcinogenesis. 21:2000;505-515.
20. Morgenstern L., Yamakawa T., Seltzer D. Carcinoma of the gastric stump. Am. J. Surg. 125:1973;29-38.
21. Hughes E.S., McDermott F.T., Polglase A.L., Johnson W.R. Tumor recurrence in the abdominal wall scar tissue after large-bowel cancer surgery. Dis. Colon Rectum. 26:1983;571-572.
22. Reilly W.T., Nelson H., Schroeder G., Wieand H.S., Bolton J., O'Connell M.J. Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis. Colon Rectum. 39:1996;200-207.
23. Breen E., Bleday R. Preservation of the anus in the therapy of distal rectal cancers. Surg. Clin. North Am. 77:1997;71-83.
24. Berends F.J., Kazemier G., Bonjer H.J., Lange J.F. Subcutaneous metastases after laparoscopic colectomy. Lancet. 344:1994;58.
25. Martinez J., Targarona E.M., Balague C., Pera M., Trias M. Port site metastasis. An unresolved problem in laparoscopic surgery. A review. Int. Surg. 80:1995;315-321.
26. Vukasin P., Ortega A.E., Greene F.L., Steele G.D., Simons A.J., Anthone G.J., Weston L.A., Beart R.W. Jr. Wound recurrence following laparoscopic colon cancer resection. Results of the American Society of Colon and Rectal Surgeons Laparoscopic Registry. Dis. Colon Rectum. 39:1996;S20-S23.
27. Nduka C.C., Darzi A. Port-site metastasis in patients undergoing laparoscopy for gastrointestinal malignancy. Br. J. Surg. 84:1997;583.
28. Baker D.G., Masterson T.M., Pace R., Constable W.C., Wanebo H. The influence of the surgical wound on local tumor recurrence. Surgery. 106:1989;525-532.
29. Skipper D., Jeffrey M.J., Cooper A.J., Alexander P., Taylor I. Enhanced growth of tumour cells in healing colonic anastomoses and laparotomy wounds. Int. J. Colorectal Dis. 4:1989;172-177.
30. Murthy S.M., Goldschmidt R.A., Rao L.N., Ammirati M., Buchmann T., Scanlon E.F. The influence of surgical trauma on experimental metastasis. Cancer. 64:1989;2035-2044.
31. Ammirati M., Rao L.N., Murthy M.S., Buchmann T., Goldschmidt R.A., Scanlon E.F. Partial nephrectomy in mice with milliwatt carbon dioxide laser and its influence on experimental metastasis. J. Surg. Oncol. 41:1989;153-159.
32. Hofer S.O., Shrayer D., Reichner J.S., Hoekstra H.J., Wanebo H.J. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch. Surg. 133:1998;383-389.
33. Lee S.W., Southall J., Allendorf J., Bessler M., Whelan R.L. Traumatic handling of the tumor independent of pneumoperitoneum increases port site implantation rate of colon cancer in a murine model. Surg. Endosc. 12:1998;828-834.
34. Braun S., Pantel K., Muller P., Janni W., Hepp F., Kentenich C.R., Gastroph S., Wischnik A., Dimpfl T., Kindermann G., Riethmuller G., Schlimok G. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N. Engl. J. Med. 342:2000;525-533.
35. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:1994;315-328.
36. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285.
37. Holmgren L., O'Reilly M.S., Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1:1995;149-153.
38. O'Reilly M.S., Holmgren L., Chen C., Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2:1996;689-692.
39. Fujimoto N., Sugita A., Terasawa Y., Kato M. Observations on the growth rate of renal cell carcinoma. Int. J. Urol. 2:1995;71-76.
40. de Giorgi V., Massi D., Gerlini G., Mannone F., Quercioli E., Carli P. Immediate local and regional recurrence after the excision of a polypoid melanoma: tumor dormancy or tumor activation? Dermatol. Surg. 29:2003;664-667.
41. Demicheli R., Valagussa P., Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases? Br. J. Cancer. 85:2001;490-492.
42. Fielding L.P., Wells B.W. Survival after primary and after staged resection for large bowel obstruction caused by cancer. Br. J. Surg. 61:1974;16-18.
43. Fisher B., Fisher E.R. Experimental evidence in support of the dormant tumor cell. Science. 130:1959;918-919.
44. Weese J.L., Ottery F.D., Emoto S.E. Do operations facilitate tumor growth? An experimental model in rats. Surgery. 100:1986;273-277.
45. Tsuchiya Y., Sawada S., Yoshioka I., Ohashi Y., Matsuo M., Harimaya Y., Tsukada K., Saiki I. Increased surgical stress promotes tumor metastasis. Surgery. 133:2003;547-555.
46. Pliskin M.E. Depression of host versus graft immunity and stimulation of tumor growth following partial hepatectomy. Cancer Res. 36:1976;1659-1663.
47. van Dale P., Galand P. Effect of partial hepatectomy on experimental liver invasion by intraportally injected colon carcinoma cells in rats. Invasion Metastasis. 8:1988;217-227.
48. de Jong K.P., Slooff M.J., de Vries E.G., Brouwers M.A., Terpstra O.T. Effect of partial liver resection on tumour growth. J. Hepatol. 1996;109-121.
49. Picardo A., Karpoff H.M., Ng B., Lee J., Brennan M.F., Fong Y. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery. 124:1998;57-64.
50. Drixler T.A., Borel Rinkes I.H.M., Ritchie E.D., van Vroonhoven T.J., Gebbink M.F., Voest E.E. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res. 60:2000;1761-1765.
51. Scheele J., Altendorf-Hofmann A. Resection of colorectal liver metastases. Langenbeck's Arch. Surg. 384:1999;313-327.
52. Arnold F., West D.C. Angiogenesis in wound healing. Pharmacol. Ther. 52:1991;407-422.
53. Abramovitch R., Marikovsky M., Meir G., Neeman M. Stimulation of tumour growth by wound-derived growth factors. Br. J. Cancer. 79:1999;1392-1398.
54. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
55. Brown L.F., Yeo K.T., Berse B., Yeo T.K., Senger D.R., Dvorak H.F., van de Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176:1992;1375-1379.
56. Brown N.J., Smyth E.A., Cross S.S., Reed M.W. Angiogenesis induction and regression in human surgical wounds. Wound Repair Regen. 10:2002;245-251.
57. Fausto N. Liver regeneration. J. Hepatol. 32:2000;19-31.
58. Court F.G., Wemyss-Holden S.A., Dennison A.R., Maddern G.J. The mystery of liver regeneration. Br. J. Surg. 89:2002;1089-1095.
59. Stolz D.B., Mars W.M., Petersen B.E., Kim T.H., Michalopoulos G.K. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res. 59:1999;3954-3960.
60. Mars W.M., Zarnegar R., Michalopoulos G.K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol. 143:1993;949-958.
61. Mochida S., Ishikawa K., Toshima K., Inao M., Ikeda H., Matsui A., Shibuya M., Fujiwara K. The mechanisms of hepatic sinusoidal endothelial cell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells. J. Gastroenterol. Hepatol. 13(Suppl. S1-5):1998;S1-S5.
62. Tomiya T., Tani M., Yamada S., Hayashi S., Umeda N., Fujiwara K. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology. 103:1992;1621-1624.
63. Lindroos P.M., Zarnegar R., Michalopoulos G.K. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 13:1991;743-750.
64. Aoki M., Morishita R., Taniyama Y., Kaneda Y., Ogihara T. Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases. J. Atheroscler. Thromb. 7:2000;71-76.
65. Aoki M., Morishita R., Taniyama Y., Kida I., Moriguchi A., Matsumoto K., Nakamura T., Kaneda Y., Higaki J., Ogihara T. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis. Gene Ther. 7:2000;417-427.
66. Drixler T.A., Vogten M.J., Gebbink M.F., Carmeliet P., Voest E.E., Borel Rinkes I.H.M. Plasminogen mediates liver regeneration and angiogenesis after partial hepatectomy in mice. Br. J. Surg. 90:2003;1384-1390.
67. Shimizu M., Hara A., Okuno M., Matsuno H., Okada K., Uesima S., Matsuo O., Niwa M., Akita K., Yamada Y., Yoshimi N., Uematsu T., Koijima S., Friedman S.L., Moriwaki H., Mori H. Hepatology. 34:2001;683-689.
68. Drixler T.A., Vogten M.J., Ritchie E.D., van Vroonhoven T.J., Gebbink M.F., Voest E.E., Borel Rinkes I.H.M. Liver regeneration is an angiogenesis-associated phenomenon. Ann. Surg. 236:2002;703-711.
69. Vogten M.J., Smakman N., Voest E.E., Borel Rinkes I.H.M. Intravital analysis of microcirculation in the regenerating mouse liver. J. Surg. Res. 113:2003;264-269.
70. Bondestam J., Salven P., Jaaskela-Saari H., Ikonen T., Lepantalo M., Mattila S., Joensuu H. Major surgery increases serum levels of vascular endothelial growth factor only temporarily. Am. J. Surg. 179:2000;57-59.
71. McDonnell C.O., Harmey J.H., Bouchier-Hayes D.J., Walsh T.N. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer. Br. J. Surg. 88:2001;1105-1109.
72. Ikeda M., Furukawa H., Imamura H., Shimizu J., Ishida H., Masutani S., Tatsuta M., Kawasaki T., Satomi T. Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor, gastric. Cancer. 5:2002;137-141.
73. Spence G.M., Graham A.N., Mulholland K., McAllister I., Sloan J.M., Armstrong M.A., Campbell F.C., McGuigan J.A. Vascular endothelial growth factor levels in serum and plasma following esophageal cancer resection - relationship to platelet count. Int. J. Biol. Markers. 17:2002;119-124.
74. Maniwa Y., Okada M., Ishii N., Kiyooka K. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest. 114:1998;1668-1675.
75. Lee S.H., Wolf P.L., Escudero R., Deutsch R., Jamieson S.W., Thistlethwaite P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342:2000;626-633.
76. Corral C.J., Siddiqui A., Wu L., Farrell C.L., Lyons D., Mustoe T.A. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch. Surg. 134:1999;200-205.
77. Brahimi-Horn C., Berra E., Pouyssegur J. Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol. 11:2001;S32-S36.
78. Wang G.L., Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. U. S. A. 90:1993;4304-4308.
79. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshert E., Keshet E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490. (Erratum in: Nature 395 (1998) 525).
80. Bos R., Zhong H., Hanrahan C.F., Mommers E.C., Semenza G.L., Pinedo H.M., Abeloff M.D., Simons J.W., van Diest P.J., van der Wall W.E. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93:2001;309-314.
81. Semenza G.L. Involvement of hypoxia-inducible factor 1 in human cancer. Intern. Med. 41:2002;79-83.
82. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835.
83. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
84. Man K., Fan S.T., Ng I.O., Lo C.M., Liu C.L., Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann. Surg. 226:1997;704-711.
85. Buell J.F., Koffron A., Yoshida A., Hanaway M., Lo A., Layman R., Cronin D.C., Posner M.C., Millis J.M. Is any method of vascular control superior in hepatic resection of metastatic cancers? Longmire clamping, pringle maneuver, and total vascular isolation. Arch. Surg. 136:2001;569-575.
86. Scott D.J., Fleming J.B., Watumull L.M., Lindberg G., Tesfay S.T., Jones D.B. The effect of hepatic inflow occlusion on laparoscopic radiofrequency ablation using simulated tumors. Surg. Endosc. 16:2002;1286-1291.
87. Patterson E.J., Scudamore C.H., Owen D.A., Nagy A.G., Buczkowski A.K. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann. Surg. 227:1998;559-565.
88. Shibata T., Murakami T., Ogata N. Percutaneous microwave coagulation therapy for patients with primary and metastatic hepatic tumors during interruption of hepatic blood flow. Cancer. 88:2000;302-311.
89. Moller P.H., Hannesson P.H., Ivarsson K., Olsrud J., Stenram U., Tranberg K.G. Interstitial laser thermotherapy in pig liver: effect of inflow occlusion on extent of necrosis and ultrasound image. Hepato-gastroenterol. 44:1997;1302-1311.
90. Albrecht D., Germer C.T., Isbert C., Ritz J.P., Roggan A., Muller G., Buhr H.J. Interstitial laser coagulation: evaluation of the effect of normal liver blood perfusion and the application mode on lesion size. Lasers Surg. Med. 23:1998;40-47.
91. te Velde E.A., van Diest P.J., Fioole B., Draaisma W.A., van der Groep P., Greijer A., van der Wall W.E., Voest E.E., Borel Rinkes I.H.M. Vascular clamping during hepatic surgery for colorectal metastases worsens prognosis. Lancet. 2004;. submitted.
92. Thomas G.M. Raising hemoglobin: an opportunity for increasing survival? Oncology. 63(Suppl. 2):2002;19-28.
93. Spence R.K., Carson J.A., Poses R., McCoy S., Pello M., Alexander J., Popovich J., Norcross E., Camishion R.C. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am. J. Surg. 159:1990;320-324.
94. Dunst J., Kuhnt T., Strauss H.G., Krause U., Pelz T., Koelbl H., Haensgen G. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int. J. Radiat. Oncol. Biol. Phys. 56:2003;778-787.
95. Sano J., Sugiyama Y., Kunieda K., Sano B., Saji S. Therapeutic effect of TNP-470 on spontaneous liver metastasis of colon tumors in the rabbit. Surg. Today. 30:2000;1100-1106.
96. Kerbel R.S. Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results. J. Clin. Oncol. 19:2001;45S-51S.
97. http://www.nci.nih.gov/.
98. Kerbel R., Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev., Cancer. 2:2002;727-739.
99. Uhr J.W., Scheuermann R.H., Street N.E., Vitetta E.S. Cancer dormancy: opportunities for new therapeutic approaches. Nat. Med. 3:1997;505-509.
100. Groen H.J., de Vries E.G., Wynendaele E., van der Graaf W.T., Lechuga E.F., Pogessi I., Dirix L.Y., van Oosterom A.T. PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic study. Clin. Cancer Res. 7:2001;3928-3933.
101. Zangari M., Barlogie B., Thertulien R., Jacobson J., Eddleman P., Fink L., Fassas A., Van Rhee F., Talamo G., Lee C.K., Tricot G. Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival. Clin. Lymphoma. 4:2003;32-35.
102. Kuenen B.C., Rosen L., Smit E.F., Parson M.R., Levi M., Ruijter R., Huisman H., Kedde M.A., Noordhuis P., van der Vijgh W.J., Peters G.J., Cropp G.F., Scigalla P., Hoekman K., Pinedo H.M., Giaccone G. Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors. J. Clin. Oncol. 6:2002;1657-1667.
103. Kuenen B.C., Levi M., Meijers J.C., Kakkar A.K., van Hinsbergh V.W., Kostense P.J., Pinedo H.M., Hoekman K. Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients. Arterioscler. Thromb. Vasc. Biol. 22:2002;1500-1505.
104. O'Reilly M.S., Pirie-Shepherd S., Lane W.S., Folkman J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science. 285:1999;1926-1928.
105. Klein S.A., Bond S.J., Gupta S.C., Yacoub O.A., Anderson G.L. Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing. J. Surg. Res. 82:1999;268-274.
106. Tanaka H., Taniguchi H., Mugitani T., Koishi Y., Masuyama M., Koyama H., Hoshima M., Takahashi T. Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing. Br. J. Surg. 83:1996;1444-1447.
107. Lange-Asschenfeldt B., Velasco P., Streit M., Hawighorst T., Pike S.E., Tosato G., Detmar M. The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses. J. Invest. Dermatol. 117:2001;1036-1041.
108. Streit M., Velasco P., Riccardi L., Spencer L., Brown L.F., Janes L., Lange-Asschenfeldt B., Yano K., Hawighorst T., Iruela-Arispe L., Detmar M. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J. 19:2000;3272-3282.
109. Gelaw B., Levin S. Wound-induced angiogenesis and its pharmacologic inhibition in a murine model. Surgery. 130:2001;497-501.
110. Haroon Z.A., Amin K., Saito W., Wilson W., Greenberg C.S., Dewhirst M.W. SU5416 delays wound healing through inhibition of TGF-beta 1 activation. Cancer Biol. Ther. 1:2002;121-126.
111. Wood J.M., Bold G., Buchdunger E., Cozens R., Ferrari S., Frei J., Hofmann F., Mestan J., Mett H., O'Reilly T., Persohn E., Rosel J., Schnell C., Stover D., Theuer A., Towbin H., Wenger F., Woods-Cook K., Menrad A., Siemeister G., Schirner M., Thierauch K.H., Schneider M.R., Drevs J., Martiny-Baron G., Totzke F. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 60:2000;2178-2189.
112. Berger A.C., Feldman A.L., Gnant M.F., Kruger E.A., Sim B.K., Hewitt S., Figg W.D., Alexander H.R., Libutti S.K. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. J. Surg. Res. 91:2000;26-31.
113. Bloch W., Huggel K., Sasaki T., Grose R., Bugnon P., Addicks K., Timpl R., Werner S. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J. 14:2000;2373-2376.
114. Balcom J.H., Keck T., Warshaw A.L., Antoniu B., Lauwers G.Y., Fernandez-del Castillo C. Perioperative matrix metalloproteinase inhibition therapy does not impair wound or anastomotic healing. J. Gastrointest. Surg. 6:2002;488-495.
115. Witte M.B., Thornton F.J., Kiyama T., Efron D.T., Schulz G.S., Moldawer L.L., Barbul A. Metalloproteinase inhibitors and wound healing: a novel enhancer of wound strength. Surgery. 124:1998;464-470.
116. Pickleman J., Watson W., Cunningham J., Fisher S.G., Gamelli R. The failed gastrointestinal anastomosis: an inevitable catastrophe? J. Am. Coll. Surg. 188:1999;473-482.
117. Thornton F.J., Barbul A. Healing in the gastrointestinal tract. Surg. Clin. North Am. 77:1997;549-573.
118. Garcia-Olmo D.C., Paya J., Garcia-Olmo D. Effects of perioperative treatment with TNP-470 on the resistance of colonic anastomoses in rats. Dig. Surg. 17:2000;154-159.
119. Hendriks J.M., Hubens G., Wuyts F.L., Vermeulen P., Hubens A., Eyskens E. Experimental study of intraperitoneal suramin on the healing of colonic anastomoses. Br. J. Surg. 86:1999;1171-1175.
120. McNamara D.A., Walsh T.N., Kay E., Bouchier-Hayes D.J. Neoadjuvant antiangiogenic therapy with tamoxifen does not impair gastrointestinal anastomotic repair in the rat. Colorectal Dis. 5:2003;335-341.
121. Kiyama T., Onda M., Tokunaga A., Efron D.T., Barbul A. Effect of matrix metalloproteinase inhibition on colonic anastomotic healing in rats. J. Gastrointest. Surg. 5:2001;303-311.
122. Syk I., Agren M.S., Adawi D., Jeppsson B. Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br. J. Surg. 88:2001;228-234.
123. de Hingh I.H., Siemonsma M.A., de Man B.M., Lomme R.M., Hendriks T. The matrix metalloproteinase inhibitor BB-94 improves the strength of intestinal anastomoses in the rat. Int. J. Colorectal Dis. 17:2002;348-354.
124. te Velde E.A., Voest E.E., van Gorp J.M., Verheem A., Hagendoorn J., Gebbink M.F., Borel Rinkes I.H.M. Adverse effects of the antiangiogenic agent angiostatin on the healing of experimental colonic anastomoses. Ann. Surg. Oncol. 9:2002;303-309.
125. Hendriks T., Mastboom W.J. Healing of experimental intestinal anastomoses. Parameters for repair. Dis. Colon Rectum. 33:1990;891-901.
126. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science. 276:1997;60-66.
127. Greene A.K., Wiener S., Puder M., Yoshida A., Shi B., Perez-Atayde A.R., Efstathiou J.A., Holmgren L., Adamis A.P., Rupnick M., Folkman J., O'Reilly M.S. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann. Surg. 237:2003;530-535.
128. Tanaka H., Taniguchi H., Mugitani T., Koishi Y., Masuyama M., Kayama H., Hoshima M., Takahashi T. Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing. Br. J. Surg. 83:1996;1444-1447.